ATP production and TCA activity are stimulated by propionyl-L-carnitine in the diabetic rat heart

Drugs in R and D

Volumn 9, Issue 2, 2008, Pages 83-91

  Broderick, Tom L ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Diabetes mellitus; Heart function; Propionyl carnitine, pharmacodynamics

Indexed keywords

ADENOSINE TRIPHOSPHATE; DRINKING WATER; GLUCOSE; PALMITIC ACID; PROPIONYLCARNITINE; STREPTOZOCIN; TRICARBOXYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE OXIDATION; GLUCOSE UTILIZATION; HEART FUNCTION; HEART MUSCLE; HEART PERFUSION; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TREATMENT OUTCOME;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD GLUCOSE; CARNITINE; CITRIC ACID CYCLE; DIABETES MELLITUS, EXPERIMENTAL; MALE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 39849088181     PISSN: 11745886     EISSN: None     Source Type: Journal    
DOI: 10.2165/00126839-200809020-00003     Document Type: Article

References (31)

1. Fisher BM, Gillen G, Lindop GBM, et al. Cardiac function and coronary arteriography in asymptomatic type I (insulin-dependent) diabetic patients: evidence for a specific diabetic heart disease. Diabetologia 1986; 29: 706-12
2. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev 2004; 4: 543-67
3. Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetes in the Framingham population. Diabetes 1974; 23: 105-11
4. Kannel WB, Hjortland M, Castelli WP. The role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34: 29-34
5. Ferrari R, Merli E, Cicchitelli G, et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci 2004; 1033: 79-91
6. Arsenian MA. Carnitine and its derivatives in cardiovascular disease. Prog Cardiovasc Dis 1997; 40: 265-86
7. Bartels GL, Remme WJ, Pillay M, et al. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 1992; 20: 157-64
8. Ferrari R, DeGuili F. The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. J Card Fail 1997; 3: 217-24
9. Anand I, Chandrashekhan AI, DeGiuli F, et al. Acute and chronic effects of propionyl-L-carnitine on the hemodynamics, exercise capacity, and hormones in patients with congestive heart failure. Cardiovasc Drugs Ther 1998; 12: 291-9
10. Broderick TL, Haloftis G, Paulson DJ. L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. J Mol Cell Cardiol 1996; 28: 331-40
11. Felix C, Gillis M, Driedzic WR, et al. Effects of propionyl-L-carnitine on isolated mitochondrial respiration in the reperfused diabetic rat heart. Diabetes Res Clin Pract 2001; 53: 17-24
12. Broderick TL, Paulson DH, Gillis M. Effects of propionyl-L-carnitine on mitochondrial respiration and post-ischaemic cardiac function in the ischaemic underperfused diabetic rat heart. Drugs R&D 2004; 5: 191-201
13. Paulson DJ, Shug AL, Zhao J. Protection of the ischemic diabetic heart by L-propionylcarnitine therapy. Mol Cell Biochem 1992; 116: 131-7
14. Terada R, Matsubara T, Koh N, et al. Effects of propionyl-L-carnitine on cardiac dysfunction in streptozotocin-diabetic rats. Eur J Pharmacol 1998; 357: 185-91
15. Broderick TL, Driedzic W, Paulson DJ. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat. Mol Cell Biochem 2000; 206: 151-7
16. Paulson DJ, Traxler J, Schmidt M, et al. Protection of the ischaemic myocardium by L-propionylcarnitine: effects on recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. Cardiovasc Res 1986; 20: 536-41
17. Liedtke AJ, DeMaison L, Nellis S. Effects of L-propionylcarnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988; 255: H169-76
18. Tassani V, Cattapan F, Magnanimi L, et al. Anaplerotic effect of propionyl-L-carnitine in rat heart mitochondria. Biochem Biophys Res Comm 1994; 198: 949-52
19. Lysiak W, Lilly K, DiLisa F, et al. Quantification of the effect of L-carnitine on the levels of acid-soluble short-chain acyl CoA in rat heart and liver mitochondria. J Biol Chem 1988; 263: 1511-6
20. Broderick TL, Quinney HA, Lopaschuk GD. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. J Biol Chem 1992; 267: 3758-63
21. Taegtmeyer H, Passmore JM. Defective energy metabolism in the heart in diabetes. Lancet 1985; 1: 139-41
22. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996; 7: 116-23
23. Rodrigues B, Cam MC, McNeill JH. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 1995; 27: 169-79
24. Garvey WT, Hardin D, Juhaszova M, et al. Effects of diabetes on myocardial glucose transporter systems in rats: implications for diabetic cardiomyopathy. Am J Physiol 1993; 264: H837-H44
25. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093-129
26. TL Broderick, M Gillis, P Poirier. Exercise training restores abnormal myocardial glucose utilization and cardiac function in diabetes. Diab Metabol Res Rev 2005; 21: 44-50
27. McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. Am J Physiol 1990; 259: H1070-85
28. McCormack JG, Barr RL, Wolff AA, et al. Ranolazine stimulates glucose oxidation in the normoxic, ischemic and reperfused ischemic hearts. Circulation 1996; 93: 135-42
29. Packer L, Valenza M, Serbinova E, et al. Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart. Arch Biobolism: chem Biophys 1991; 288: 533-7
30. Kerbey AL, Vary TC, Randle PJ. Molecular mechanisms regu-lating glucose oxidation. Basic Res Cardiol 1985; 80 Suppl. 2: 93-6
31. Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischemia in diabetic rat heart. Cardiovasc Res 1995; 29: 373-8